AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist

0.066
0.0000.00%

20min DelayTrading Jul 11 10:15 AET

4.96MMarket Cap-640P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Jun 30, 2023

(FY)Jun 30, 2022

(FY)Jun 30, 2021

(FY)Jun 30, 2020

Operating cash flow (direct method)

Cash income from operating activities

151.90%459.09K

182.25K

Other cash income from operating activities

151.90%459.09K

--182.25K

----

----

Cash paid

-123.29%-8.13M

-98.08%-3.64M

-3.84%-1.84M

-1.77M

Payments to suppliers for goods and services

-123.29%-8.13M

-98.08%-3.64M

-3.84%-1.84M

---1.77M

Direct interest received

897.84%797.08K

-49.69%79.88K

-4.17%158.79K

--165.7K

Operating cash flow

-103.43%-6.87M

-101.20%-3.38M

-4.67%-1.68M

---1.6M

Investing cash flow

Cash flow from continuing investing activities

Cash from discontinued investing activities

Financing cash flow

Cash flow from continuing financing activities

-48.56%8.09M

15.73M

Net common stock issuance

----

----

-43.91%8.09M

--14.43M

Net other financing activities

----

----

----

--1.3M

Cash from discontinued financing activities

Financing cash flow

----

----

-48.56%8.09M

--15.73M

Net cash flow

Beginning cash position

-10.32%29.34M

24.39%32.72M

116.10%26.3M

--12.17M

Current changes in cash

-103.43%-6.87M

-152.63%-3.38M

-54.60%6.42M

--14.13M

End cash Position

-23.41%22.47M

-10.32%29.34M

24.39%32.72M

--26.3M

Free cash from

-103.43%-6.87M

-101.20%-3.38M

-4.67%-1.68M

---1.6M

Accounting Standards

US-GAAP

US-GAAP

US-GAAP

US-GAAP

	(FY)Jun 30, 2023	(FY)Jun 30, 2022	(FY)Jun 30, 2021	(FY)Jun 30, 2020
Operating cash flow (direct method)
Cash income from operating activities	151.90%459.09K	182.25K
Other cash income from operating activities	151.90%459.09K	--182.25K	----	----
Cash paid	-123.29%-8.13M	-98.08%-3.64M	-3.84%-1.84M	-1.77M
Payments to suppliers for goods and services	-123.29%-8.13M	-98.08%-3.64M	-3.84%-1.84M	---1.77M
Direct interest received	897.84%797.08K	-49.69%79.88K	-4.17%158.79K	--165.7K
Operating cash flow	-103.43%-6.87M	-101.20%-3.38M	-4.67%-1.68M	---1.6M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities			-48.56%8.09M	15.73M
Net common stock issuance	----	----	-43.91%8.09M	--14.43M
Net other financing activities	----	----	----	--1.3M
Cash from discontinued financing activities
Financing cash flow	----	----	-48.56%8.09M	--15.73M
Net cash flow
Beginning cash position	-10.32%29.34M	24.39%32.72M	116.10%26.3M	--12.17M
Current changes in cash	-103.43%-6.87M	-152.63%-3.38M	-54.60%6.42M	--14.13M
End cash Position	-23.41%22.47M	-10.32%29.34M	24.39%32.72M	--26.3M
Free cash from	-103.43%-6.87M	-101.20%-3.38M	-4.67%-1.68M	---1.6M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

AU

Overall